What USGI Medical does

USGI Medical, Inc. is a privately held medical device manufacturer founded in 2001 and headquartered in San Clemente, California. The company develops endoluminal technologies that enable incisionless surgical procedures performed through the natural passageways of the body, eliminating the need for external incisions in soft tissue approximation and certain bariatric interventions. Its core offering is the Incisionless Operating Platform (IOP), an integrated system that combines the TransPort four-channel steerable overtube with the g-Cath EZ suture delivery catheter, the g-Prox EZ tissue grasper, the g-Lix tissue retractor, and the patented Snowshoe Suture Anchors, which together approximate gastric tissue through full-thickness plication without manual knot tying. The company's regulated indications include FDA clearance for soft tissue approximation in minimally invasive gastroenterology procedures, CE Mark approval extending to obesity intervention for patients with BMI 30-40, and an active FDA investigation under a Pivotal Study for the POSE 2.0 incisionless weight loss procedure. More than 16,000 patients have been treated with the company's devices to date. USGI Medical operates a direct sales model selling hardware and consumables to healthcare providers, gastroenterologists, bariatric surgeons, and obesity treatment centers through telephone, email, and a small direct sales force, with global scope claimed via its CE Mark. The company is led by CEO Carlos Babini, Chairman Guy P. Nohra, and COO Tracy Maahs, and has raised approximately $81.5M in disclosed funding across six rounds between 2001 and 2015, with no publicly disclosed round since.

Name

USGI Medical

Legal name

USGI Medical, Inc.

Website

https://usgimedical.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

USGI Medical is a privately held medical device company that develops and sells the Incisionless Operating Platform (IOP), an integrated endoluminal system enabling incisionless soft tissue approximation and obesity procedures, serving gastroenterologists, bariatric surgeons, and hospitals.

Ownership category

akta.pro rank

Product category

Endoluminal Surgical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

akta.pro secondary industries

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Endoluminal surgical devices
• Incisionless surgery
• Bariatric medical devices
• Endoscopic suturing
• Soft tissue approximation

Headquarters

HQ city

San Clemente

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales: USGI Medical manufactures and sells endoluminal surgical devices and accessories including the TransPort system, g-Cath EZ, g-Prox EZ, g-Lix, and Snowshoe Suture Anchors. Revenue is generated through direct sales of these hardware products to healthcare providers and hospitals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

USGI Medical manufactures and sells endoluminal surgical devices that enable incisionless procedures through the natural passageways of the body. Its Incisionless Operating Platform (IOP) integrates devices such as the TransPort 4-channel overtube, g-Cath EZ suture delivery catheter, g-Prox EZ tissue grasper, g-Lix tissue retractor, and patented Snowshoe Suture Anchors, used for soft tissue approximation in minimally invasive gastroenterology and bariatric/obesity procedures.

Product overview

USGI Medical offers the Incisionless Operating Platform (IOP), a unified platform enabling incisionless surgery through endoluminal technologies. The platform integrates multiple modules including TransPort (4-channel overtube access device), g-Cath EZ (suture delivery catheter), g-Prox EZ (tissue grasper), g-Lix (tissue retractor), and Snowshoe Suture Anchors (soft tissue anchors). These components work together to enable endoscopic soft tissue approximation and suturing without external incisions, primarily用于 minimally invasive gastroenterology procedures and obesity intervention.

Differentiator

Problem solved

Functional benefit

Products and services

• TransPort (4-Channel Overtube & Access Device) 4-channel overtube and access device providing four working channels for accessing gastric tissue. Steerable in 4 directions like an endoscope with shape-lockable positioning to provide a stable platform during endoscopic procedures. Sold to healthcare providers and bariatric surgeons for use in minimally invasive gastroenterology.
• g-Cath EZ (Snowshoe Suture Delivery Catheter) Suture delivery catheter including a single Snowshoe anchor pair that is easily delivered to approximate gastric tissue with tactile cinching capability. Used by gastroenterologists and bariatric surgeons in minimally invasive endoscopic procedures.
• g-Prox EZ (Endoscopic Tissue Grasper) Endoscopic tissue grasper with jaws used to grasp gastric tissue and approximate a tissue fold in preparation for delivering Snowshoe Suture Anchors. Loadable and unloadable with repeated uses of g-Cath. Sold to physicians for minimally invasive GI procedures.
• g-Lix (Endoscopic Tissue Retractor) Endoscopic tissue retractor employing a helical coil tip for initially grasping gastric tissue and retracting it into the jaws of the g-Prox. Used in the Incisionless Operating Platform workflow for gastroenterology and bariatric procedures.
• Snowshoe Suture Anchors Patented expandable soft tissue anchors designed to withstand the rigors of gastrointestinal use. Provides full-thickness plication through the muscularis layer with 0 polyester braided suture acting as pledgets, enabling user-controlled cinching across different tissue types without requiring manual knot tying. Used in incisionless endoluminal procedures.
• Endoluminal Suturing (Technology Platform) Technology used to approximate soft tissue in minimally invasive gastroenterology procedures, enabling incision-free serosa-to-serosa tissue fusion with unsurpassed durability. Underpins USGI Medical's incisionless surgical procedures including obesity intervention (POSE 2.0).

Quantifiable outcome

• 16,000+ patients treated with incisionless procedures

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Boston Scientific: Large diversified medical device incumbent with a deep GI/endoscopy franchise. Post-Apollo acquisition it is both a direct competitor (OverStitch) and a channel partner; competes for the same gastroenterologist and bariatric surgeon mindshare as USGI.
• Medtronic: Diversified medtech incumbent with GI solutions (including PillCam, Bravo, Emprint) and a bariatric/metabolic presence. Competes for hospital budgets and GI specialist relationships across the same procedures USGI targets.
• Ethicon (Johnson & Johnson): Largest surgical instruments and endoscopic suturing franchise globally. Competes with USGI in soft tissue approximation, laparoscopic bariatric, and adjacent endoscopic surgery categories with significantly greater resources.
• Stryker: Major surgical and endoscopy equipment incumbent with broad hospital purchasing relationships. Adjacent competitor in minimally invasive surgical instruments and GI/endoscopy infrastructure.
• Olympus Medical: Dominant endoscopy systems OEM whose scopes, overtubes, and therapeutic accessories define the channel in which USGI's TransPort is deployed. Olympus also sells therapeutic endoscopic tools that overlap with USGI's graspers and retractors.

Direct peers

• EndoGastric Solutions: Endoluminal-focused company (EsophyX/TIF procedure for GERD) that pioneered natural orifice transluminal endoscopic surgery approaches in the upper GI tract. Comparable in clinical positioning and procedure philosophy to USGI's incisionless platform.
• Lumendi: Endoluminal interventional company developing tools for endoluminal GI procedures. Targets the same physician call point (therapeutic endoscopists) and emphasizes minimally invasive endoscopic approaches overlapping with USGI's value proposition.
• Apollo Endosurgery: Direct competitor in endoscopic bariatric and endoluminal suturing, offering the OverStitch endoscopic suturing system. Acquired by Boston Scientific in 2023, giving it significantly more capital and distribution — the most directly comparable product line to USGI's g-Cath/Snowshoe Anchor platform.

Emerging players

• Fractyl Health: Clinical-stage company developing endoscopic metabolic therapies (Revita) for type 2 diabetes and obesity. Comparable as an emerging endoluminal obesity/metabolic player targeting the same end-user (endoscopists performing endoscopic bariatric).
• Allurion Technologies: Developer of the Allurion Gastric Balloon, a non-invasive (swallowable) weight-loss intervention. Competes for the same non-surgical/incisionless obesity treatment market positioning that USGI's POSE2.0 targets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds6 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about USGI Medical